Concepedia

Holly Hammond

HH

Statistics

Publications

29

Citations

3K

H-Index

21

Active since

2003

Affiliations

University of Maryland, Baltimore(Current)

Johns Hopkins University

Johns Hopkins Medicine

Novavax (United States)

Harvard University

Holly Hammond is an author at University of Maryland, Baltimore specializing in medicine, immunology, and vaccine development.

ORCID

Top concepts

Publications per year

2003–2023

29

Publications

29

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Jing-Hui Tian, Nita Patel, Robert Haupt et al. · Nature Communications · 2021 · 517 citations · Full text

Defining the Role of Wnt/β‐Catenin Signaling in the Survival, Proliferation, and Self‐Renewal of Human Embryonic Stem Cells

Gautam Dravid, Zhaohui Ye, Holly Hammond et al. · Stem Cells · 2005 · 336 citations · Full text

Human Adult Marrow Cells Support Prolonged Expansion of Human Embryonic Stem Cells in Culture

Linzhao Cheng, Holly Hammond, Zhaohui Ye et al. · Stem Cells · 2003 · 331 citations · Full text

, , +16

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 284 citations · Full text

Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2

D. Schultz, Robert M. Johnson, Kasirajan Ayyanathan et al. · Nature · 2022 · 192 citations · Full text

, , +4

1–5 of 29